BRUCHSAL, Germany-Tuesday 9 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- CYNORA, a leader in TADF (thermally activated delayed fluorescence) materials for Next-generation OLEDs, extends its Joint Development Agreement with LG Display. After two years of joint development since 2016, CYNORA and LG Display have decided to continue their cooperation towards the commercialization of TADF emitters in OLED displays.

OLED panels are currently the dominating technology for TV and mobile applications. To enable even more applications, OLED panel makers are urgently looking for a high-efficiency deep-blue emitter material. CYNORA´s innovative TADF technology presents a new solution to this issue after the current state-of-the-art technology, phosphorescence, has not succeeded in several years.

CYNORA is the first company to demonstrate high-efficiency deep-blue emitter materials for OLED displays, while others have only reported on sky-blue materials that cannot ... Read more »

International Case Competition Offers Opportunity to Interview with P&G Through Business Problem Solving

CINCINNATI -Friday 5 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Are you a college student looking for a business competition to demonstrate your aptitude for strategy and problem-solving? If you’d like to showcase your ingenuity and critical thinking skills beyond the college campus on a global scale, then P&G’s CEO Challenge is the opportunity. The Procter & Gamble Company (P&G) (NYSE: PG) has opened the window for applications to its next Global CEO Challenge, a creative way to attract top talent to P&G. It invites students to demonstrate their business skills in several real-world scenarios, showcasing the type of work they could do for P&G brands. Apply by visiting https://www.pg-ceochallenge.com/ Deadlines vary by country.

“Students want an opportunity to demonstrate that they can put what they&rsquo ... Read more »

A significantly greater proportion of patients achieved Scalp Physician’s Global Assessment (ScPGA) response at week 16 with OTEZLA compared with placebo

SUMMIT, N.J.-Tuesday 9 October 2018 [ AETOS Wire ]

(BUSINESS WIRE)-- Celgene Corporation (NASDAQ:CELG) today announced results from the phase 3 STYLE study, which showed that OTEZLA® (apremilast) 30 mg twice daily achieved a highly statistically significant improvement in the primary endpoint of the Scalp Physician’s Global Assessment (ScPGA) response [defined as ScPGA score of clear (0) or almost clear (1) with at least a 2-point reduction from baseline] at week 16 compared with placebo.

In addition to achieving the primary endpoint, statistical significance was also met for the secondary endpoint of the whole body itch numeric rating scale (NRS) [defined as at least a 4-point reduction from baseline] at week 16 with OTEZLA versus placebo.

The safety profile was generally consistent ... Read more »

Timed with MOP1 to the WHO FCTC Protocol to Eliminate Illicit Trade in Tobacco Products, PMI Reiterates its Support of Protocol in Position Paper

LAUSANNE, Switzerland-Monday 8 October 2018 [ AETOS Wire ]

(BUSINESS WIRE) -- Philip Morris International Inc. (PMI) (NYSE:PM) is today publishing its position paper supporting the WHO FCTC Protocol to Eliminate Illicit Trade in Tobacco Products. In its paper, PMI is expressing its views on how to best tackle illicit tobacco trade as the first Meeting of the Parties to the Protocol (MOP1) kicks off in Geneva. With approximately one out of 10 cigarettes smoked globally stemming from illicit trade, Parties to the Protocol should take a collaborative approach to tackling the problem of illicit trade. Available on PMI’s website, the position paper proposes effective strategies for tackling the illicit tobacco trade, aligned with key provisions of the Protocol.

“The Protocol is a significant and crucia ... Read more »